Shares of clinical-stage company Summit Therapeutics SMMT rose nearly 9% on Thursday following a report issued by Bloomberg, ...

The new car market in the UK reported growth for the second month in a row in June, with registrations rising by 6.7% to ...

Demand for battery-electric vans surged 53 per cent in the UK in the first half of 2025. In June alone, registrations even ...

Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

New diesel van registrations shrank by 12.1% to 156,048 units in the first half of 2025, whilst electric van demand rose by ...

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

Shares of Summit Therapeutics jumped 9% Thursday on a report that it was discussing a lucrative partnership deal with AstraZeneca.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ITT Inc (Symbol: ITT), where a total of 2,245 contracts have traded so far ...

Tesla's new car sales in Britain rose year-on-year in June amid a broader recovery in the electric-vehicle market, data showed on Friday, as the U.S. auto maker started deliveries of its updated Model ...